Bristol-Myers Squibb Earnings: Here’s Why Investors are Buying Shares

Bristol-Myers Squibb Company (NYSE:BMY) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Shares are up 1.72%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Bristol-Myers Squibb Company Earnings Cheat Sheet

Results: Net income increased 8.57% to $925 million (47 cents per diluted share) in the quarter versus a net gain of $852 million in the year-earlier quarter.

Revenue: Decreased 23.18% to $4.19 billion from the year-earlier quarter.

Actual vs. Wall St. Expectations: Bristol-Myers Squibb Company reported adjusted net income of 47 cents per share. By that measure, the company beat the mean analyst estimate of $0.43. It beat the average revenue estimate of $4.12 billion.

Quoting Management: “With regulatory approvals for Eliquis and Forxiga, and good operating performance in the fourth quarter, Bristol-Myers Squibb had a strong finish to an important year of transition,” said Lamberto Andreotti, chief executive officer, Bristol-Myers Squibb…